Holen Sie sich die Stockscreener-App
262.50
1.03%
-2.555
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt THC?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$265.05
Offen:
$261.07
24-Stunden-Volumen:
173.86K
Relative Volume:
0.15
Marktkapitalisierung:
$21.16B
Einnahmen:
$21.46B
Nettoeinkommen (Verlust:
$2.65B
KGV:
13.65
EPS:
19.2312
Netto-Cashflow:
$3.35B
1W Leistung:
-1.32%
1M Leistung:
+0.08%
6M Leistung:
+10.71%
1J Leistung:
+36.30%
1-Tages-Spanne:
$260.77
$266.75
1-Wochen-Bereich:
$253.51
$267.81
52-Wochen-Spanne:
$157.58
$283.05
Tenet Healthcare Corp Stock (THC) Company Profile
Firmenname
Tenet Healthcare Corp
Sektor
Branche
Telefon
469-893-2200
Adresse
14201 DALLAS PARKWAY, DALLAS, TX
Compare THC vs HCA, FMS, EHC, DVA
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
THC
Tenet Healthcare Corp
|
262.81 | 21.34B | 21.46B | 2.65B | 3.35B | 19.23 |
HCA
Hca Healthcare Inc
|
403.24 | 87.68B | 76.39B | 7.81B | 7.93B | 29.08 |
FMS
Fresenius Medical Care Ag Adr
|
22.50 | 12.06B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
121.37 | 12.01B | 6.07B | 793.80M | 464.40M | 5.9914 |
DVA
Davita Inc
|
181.17 | 11.74B | 13.84B | 1.10B | 1.49B | 10.42 |
Tenet Healthcare Corp Stock (THC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-14 | Fortgesetzt | Goldman | Buy |
| 2025-07-28 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2025-05-29 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-04-15 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-03-26 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-02-26 | Eingeleitet | TD Cowen | Buy |
| 2024-12-17 | Fortgesetzt | JP Morgan | Overweight |
| 2024-12-16 | Herabstufung | Goldman | Buy → Neutral |
| 2024-11-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-11-22 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-27 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-04-19 | Eingeleitet | JP Morgan | Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-03-29 | Eingeleitet | Wells Fargo | Overweight |
| 2022-02-10 | Hochstufung | UBS | Neutral → Buy |
| 2022-02-09 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2022-02-09 | Hochstufung | Truist | Hold → Buy |
| 2022-01-20 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2022-01-10 | Fortgesetzt | Citigroup | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-09-24 | Eingeleitet | UBS | Neutral |
| 2021-08-12 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-07-23 | Fortgesetzt | Citigroup | Buy |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Buy |
| 2021-05-03 | Fortgesetzt | Goldman | Buy |
| 2021-01-08 | Hochstufung | Jefferies | Hold → Buy |
| 2021-01-05 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-12-15 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-09-21 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-03-11 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-02-26 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2019-12-09 | Hochstufung | UBS | Neutral → Buy |
| 2019-11-06 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2019-08-14 | Fortgesetzt | Goldman | Neutral |
| 2019-02-26 | Bestätigt | BofA/Merrill | Neutral |
| 2019-01-14 | Eingeleitet | Stephens | Equal-Weight |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Hold |
| 2018-12-17 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2018-11-16 | Eingeleitet | UBS | Neutral |
| 2018-06-29 | Herabstufung | Jefferies | Buy → Hold |
| 2018-03-23 | Fortgesetzt | Mizuho | Buy |
| 2018-01-30 | Fortgesetzt | Wells Fargo | Market Perform |
| 2018-01-03 | Eingeleitet | Goldman | Neutral |
| 2017-12-20 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2017-12-19 | Bestätigt | Mizuho | Neutral |
| 2017-12-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2017-12-12 | Hochstufung | Citigroup | Neutral → Buy |
Alle ansehen
Tenet Healthcare Corp Aktie (THC) Neueste Nachrichten
THC Looks 42.8% Overvalued on GF Value™ - GuruFocus
Tenet Healthcare offers $1.5B notes to refinance 2027 debt - Investing.com
Tenet could refinance $1.5B due in 2027 with notes due in 2034. - Stock Titan
ETFs Investing in Tenet Healthcare Corporation Stocks - TradingView
HCA Healthcare Inc. stock underperforms Friday when compared to competitors - MarketWatch
BlackRock controls millions of Tenet Healthcare (NYSE: THC) shares, but how much voting power is solely its own? - Stock Titan
Tenet Healthcare (NYSE:THC) Looks Like a Decent Value Stock With Strong Profitability - ChartMill
Tenet Healthcare director Nadja West sells $298,137 in stock By Investing.com - Investing.com South Africa
Tenet Healthcare director Nadja West sells $298,137 in stock - Investing.com
Tenet Healthcare (NYSE: THC) director sells about $298K in shares - Stock Titan
HCA Healthcare Inc. stock outperforms competitors on strong trading day - MarketWatch
Director at Tenet Healthcare (NYSE: THC) plans 1,152-share Rule 144 stock sale in September 2026 - Stock Titan
Lisa Y Foo Takes Money Off The Table, Sells $6.39M In Tenet Healthcare Stock - Benzinga
Tenet Healthcare and Archrock have been highlighted as Zacks Bull and Bear of the Day - Yahoo Finance
Tenet to Participate in the Wells Fargo Healthcare Conference - Barchart.com
Tenet Healthcare COO Lisa Foo sells $6.39m in shares By Investing.com - Investing.com Australia
Tenet Healthcare COO Lisa Foo sells $6.39m in shares - Investing.com
Tenet Healthcare Corporation (THC) Peer Comparison – Compare with Others - Value Research
Charitable stock gift trims Tenet (THC) insider’s direct stake to 12,403 shares - Stock Titan
Tenet (THC) officer discloses new stock sale after July trade - Stock Titan
Tenet Healthcare Corporation (THC) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
CEO At Tenet Healthcare Sells $27.64M Of Stock - Benzinga
Tenet healthcare CEO Saumya Sutaria sells $27.6m in shares By Investing.com - Investing.com Nigeria
Tenet healthcare director Cecil Haney sells $361,438 in stock By Investing.com - Investing.com Canada
Tenet Healthcare (NYSE: THC) holder plans new sale after $13.9M trade - Stock Titan
Tenet Healthcare (NYSE: THC) director lines up $361K share sale - Stock Titan
Tenet Healthcare (THC): Sutaria files 50,000-share resale notice - Stock Titan
Tenet Healthcare Corp (THC) Stock Up 3.0% but GF Value Says Over - GuruFocus
Tenet Healthcare Corp (MIL:1THC) Stock Price, Trades & News - GuruFocus
Tenet (THC) Is Considered a Good Investment by Brokers: Is That True? - Yahoo Finance
Zacks Industry Outlook Highlights Tenet Healthcare, Universal Health Services, Acadia Healthcare and Community Health Systems - Eastern Progress
HCA Healthcare Inc. stock outperforms competitors despite losses on the day - MarketWatch
Tenet Healthcare stock hits all-time high at 270.79 USD - Investing.com
Zacks.com featured highlights include Centene, Tenet Healthcare, Fortinet, Unity Software and Goldman Sachs - Zacks Investment Research
Can Tenet Healthcare's Hospital Growth Keep Earnings Momentum Going? - Yahoo Finance
Tenet Healthcare director Roy Blunt sells $157,608 in company stock By Investing.com - Investing.com South Africa
Tenet Healthcare Corp (THC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - tradingkey.com
Tenet Healthcare director Roy Blunt sells $157,608 in company stock - Investing.com
Tenet Healthcare (NYSE:THC) Lowered to "Buy" Rating by Wall Street Zen - MarketBeat
Tenet Healthcare Faces 30%-35% Downside After Its 26-Fold Surge - Investing.com
T. Rowe Price stakes 9.2% in Tenet Healthcare (THC) with 7.96M shares - Stock Titan
Are Investors Undervaluing Tenet Healthcare (THC) Right Now? - Yahoo Finance
Tenet Healthcare Corporation (THC) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
Zacks Research Brokers Boost Earnings Estimates for THC - MarketBeat
Is Tenet Healthcare (THC) Overvalued Following Higher 2026 Adjusted EPS Guidance? - simplywall.st
Tenet Healthcare (THC) Could Be 7% Above Fair Value As Golden Cross Draws Focus - Yahoo Finance
Tenet Healthcare (NYSE:THC) Rating Increased to Strong-Buy at Zacks Research - MarketBeat
Is Tenet’s Golden Cross, Higher EPS Guidance and Ambulatory Push Altering The Investment Case For Tenet Healthcare (THC)? - Yahoo Finance
Tenet Healthcare (NYSE:THC) Sets New 1-Year HighStill a Buy? - MarketBeat
Here's How Much You'd Have If You Invested $1000 in Tenet Healthcare a Decade Ago - Yahoo Finance
Wedge Capital Management L L P NC Grows Holdings in Tenet Healthcare Corporation $THC - MarketBeat
Finanzdaten der Tenet Healthcare Corp-Aktie (THC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.54%
0.58%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):